Thermo Fisher Scientific (TMO) and Roche (RHHBY) Renew Partnership for Improved Detection of Sepsis Using PCT Biomarker
7/30/2013 10:03:52 AM
Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
HENNIGSDORF, Germany--(BUSINESS WIRE)--Thermo Fisher Scientific Inc., the world leader in serving science, today announced the renewal of its non-exclusive, long-term, royalty-bearing agreement with Roche for the use of Thermo Fisher’s Procalcitonin (B.R.A.H.M.S PCTTM) technology, currently available as an automated immunoassay on the Roche Elecsys® cobas e platforms in all countries outside the United States. The agreement extends a long-standing relationship between the companies.
Help employers find you! Check out all the jobs and post your resume.
comments powered by